Cytosorbents Corporation
CTSO
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevā¦ read more
Healthcare
Medical Devices
19 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$0.36
Price+3.09%
$0.01
1Y
Price
Market Cap
$22.680m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-30.8%
EBITDA Margin-33.4%
Net Profit Margin-16.3%
Free Cash Flow Margin-30.8%
EBITDA Margin-33.4%
Net Profit Margin-16.3%
Free Cash Flow MarginRevenue
$37.200m
+3.9%
1y CAGR+2.7%
3y CAGR-1.4%
5y CAGREarnings
-$11.849m
+48.9%
1y CAGR+29.7%
3y CAGR+13.8%
5y CAGREPS
-$0.19
+50.0%
1y CAGR+35.0%
3y CAGR+18.3%
5y CAGRBook Value
$2.194m
$40.562m
Assets$38.368m
Liabilities$18.963m
DebtDebt to Assets
46.8%
-1.5x
Debt to EBITDAFree Cash Flow
-$10.202m
+30.1%
1y CAGR+33.3%
3y CAGR+2.5%
5y CAGRNo items found.
Press Releases
Statements and updates from the company